[News Brief] Launch of UNITED 2.0 Furthers Precision Medicine in Singapore
UNITED 2.0 was launched on 2 March 2026 at Catapult, Galaxis, in a collaborative event hosted by the National Cancer…
Pharmaceuticals & Supplements
[News Brief] HSA Warns Against Illegal Injectable Peptides Sold Online
Health Sciences Authority (HSA) has warned against the use of injectable peptides sold online in Singapore for weight loss and…
[News Brief] United Labs and Novo Nordisk Announce Phase 2 UBT251 Results
The United Laboratories International Holdings Limited and Novo Nordisk A/S announced topline results from a Chinese phase 2 trial of…
[News Brief] OneSource-Hikma Partnership Secures Approval for Generic Ozempic in Saudi Arabia
OneSource Specialty Pharma has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic® (semaglutide) in collaboration…
[News Brief] Galderma Expands Restylane Portfolio with Two New Launches in Japan
Galderma has launched Restylane Defyne and Restylane Refyne, the first Optimal Balance Technology (OBT)–based hyaluronic acid injectables authorised in Japan.…
[News Brief] Japan Approves Clinigen’s Therapeutic Human Milk Fortifier for VLBW Infants
Japan’s Ministry of Health, Labour and Welfare has approved a human milk-based fortifier for very low birth weight (VLBW) infants,…
[News Brief] ImmunityBio to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Treatment
ImmunityBio has partnered with Biopharma and Cigalah Healthcare to commercialise ANKTIVA® (nogapendekin alfa inbakicept) in Saudi Arabia for bladder and…
[News Brief] Philippine Pharma & Healthcare Expo 2026 Holds Media Interaction Ahead of 2026 Edition
The organisers of Philippine Pharma & Healthcare Expo 2026 held a media interaction to outline plans for the 2026 edition,…
[News Brief] Pharmapack Announces Expansion to Asia with Singapore Event in November 2026
Pharmapack Europe has announced the launch of a new Pharmapack Asia event in Singapore, slated for November 2026, offering a…
[News Brief] HSA Updates Brukinsa Prescribing Information on CYP3A Inhibitors
The Health Sciences Authority (HSA) has announced a correction to the Singapore prescribing information for Brukinsa Capsule 80 mg regarding…